Products for Research Use Only
RegisterLogin

Cevidoplenib dimesylate

CAT: 0957-E1836-5mgSize: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-E1836-5mgSize:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2043659-93-2
Synonyms
SKI-O-703 dimesylate
Target
Syk
Applications
Protein Tyrosine Kinase
Molecular Formula
C25H27N7O3.2CH4O3S
Additionnal Information
Cevidoplenib dimesylate (SKI-O-703 dimesylate) is an orally available inhibitor of spleen tyrosine kinase (Syk) with potential anti-inflammatory and immunomodulating activities. It attenuates the progression of autoantibody-mediated autoimmune diseases by inhibiting both autoantibody-producing and autoantibody-sensing cells.

Related Products

CatalogName
E4664-01Osimertinib dimesylate
E4664-1gOsimertinib dimesylate
E4664-100mgOsimertinib dimesylate
E4664-25mgOsimertinib dimesylate
E4664-5mgOsimertinib dimesylate
S7194-10mM/1mLOlverembatinib (GZD824) dimesylate
S1494-1gRalimetinib (LY2228820) dimesylate
S1494-50mgRalimetinib (LY2228820) dimesylate
S1494-10mM/1mLRalimetinib (LY2228820) dimesylate
S7194-01Olverembatinib (GZD824) dimesylate

Alternative Products

CatalogName
C01900-25mgCevidoplenib dimesylate
HY-109082A-01Cevidoplenib (dimesylate)
M28906-01Cevidoplenib dimesylate hydrochloride
DTC78821-01Cevidoplenib
A10545-100LY2228820 dimesylate (Ralimetinib dimesylate) 100mg
A10545-50LY2228820 dimesylate (Ralimetinib dimesylate) 50mg
A10545-25LY2228820 dimesylate (Ralimetinib dimesylate) 25mg
A10545-1LY2228820 dimesylate (Ralimetinib dimesylate) 1mg

Popular Products